...
首页> 外文期刊>Dermatologic surgery >Treatment of idiopathic cutaneous hyperchromia of the orbital region (ICHOR) with intense pulsed light.
【24h】

Treatment of idiopathic cutaneous hyperchromia of the orbital region (ICHOR) with intense pulsed light.

机译:用强脉冲光治疗眼眶区域特发性皮肤增生(ICHOR)。

获取原文
获取原文并翻译 | 示例

摘要

BACKGROUND: Idiopathic cutaneous hyperchromia of the orbital region (ICHOR) does not have a clear etiopathogenesis. Genetic factors, increased melanin, prominent vasculature, and eyelid skin slackness seem to be involved. OBJECTIVE: To evaluate individuals with ICHOR clinically and histologically, before and after treatment with high-energy pulsed light (HEPL), considering epidermal and dermal melanin, in order to evaluate HEPL efficacy in clearing away ICHOR, and 1 month and 1 year later to check whether improvement was maintained. METHODS: Twelve individuals with ICHOR underwent clinical and histological evaluation before and after HEPL application, with photographic comparison. They underwent one to four HEPL sessions on the lower eyelid at approximately 30-day intervals. Melanin quantification by area, before and after treatment was performed by digital image morphometry. RESULTS: Eyelid skin was significantly lightened (p = .24), and was maintained 1 year later with no ICHOR reincidence. All individuals (100%) showed postinflammatory hyperchromia (average 6-month duration), while 58.33% presented hypochromia (7-month duration). There was significantly decreased epidermal and dermal melanin after treatment. CONCLUSION: HEPL was shown to be useful in clearing up ICHOR. This was maintained after 1 year. Epidermal and dermal histopathology showed decreased melanin following treatment. Longer follow-up is needed to evaluate possible later recurrence of ICHOR.
机译:背景:眼眶区域特发性皮肤增生(ICHOR)没有明确的病因。似乎涉及遗传因素,黑色素增加,明显的脉管系统和眼睑皮肤松弛。目的:在临床和组织学上评估高能脉冲光(HEPL)之前和之后患有ICHOR的个体,考虑表皮和真皮黑色素,以评估HEPL清除ICHOR的功效,以及1个月和1年后检查是否保持了改进。方法:12例ICHOR患者在HEPL应用前后进行临床和组织学评估,并进行照相比较。他们以大约30天的间隔在下眼睑上进行了1-4次HEPL疗程。通过数字图像形态测定术对治疗前后的黑色素进行定量。结果:眼睑皮肤明显减轻(p = 0.24),并在1年后得以维持,无ICHOR复发。所有个体(100%)均表现为炎症后增色(平均持续6个月),而58.33%表现为体质减退(持续7个月)。治疗后,表皮和真皮黑色素明显减少。结论:HEPL被证明可用于清除ICHOR。 1年后保持不变。表皮和真皮组织病理学显示治疗后黑色素减少。需要更长的随访时间以评估ICHOR以后是否可能复发。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号